-
1
-
-
12444279265
-
On the origin of cancer cells
-
Warburg, O. (1956) On the origin of cancer cells Science 123, 309-314
-
(1956)
Science
, vol.123
, pp. 309-314
-
-
Warburg, O.1
-
2
-
-
0015251175
-
Bioenergetics and the problem of tumor growth
-
Racker, E. (1972) Bioenergetics and the problem of tumor growth Am. Sci. 60, 56-63
-
(1972)
Am. Sci.
, vol.60
, pp. 56-63
-
-
Racker, E.1
-
3
-
-
0031748828
-
The contribution of lactic acid to acidification of tumours: Studies of variant cells lacking lactate dehydrogenase
-
Yamagata, M., Hasuda, K., Stamato, T., and Tannock, I. F. (1998) The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase Br. J. Cancer 77, 1726-1731
-
(1998)
Br. J. Cancer
, vol.77
, pp. 1726-1731
-
-
Yamagata, M.1
Hasuda, K.2
Stamato, T.3
Tannock, I.F.4
-
4
-
-
43749083041
-
Brick by brick: Metabolism and tumor cell growth
-
DeBerardinis, R. J., Sayed, N., Ditsworth, D., and Thompson, C. B. (2008) Brick by brick: metabolism and tumor cell growth Curr. Opin. Genet. Dev. 18, 54-61
-
(2008)
Curr. Opin. Genet. Dev.
, vol.18
, pp. 54-61
-
-
Deberardinis, R.J.1
Sayed, N.2
Ditsworth, D.3
Thompson, C.B.4
-
5
-
-
0035131831
-
The rate-limiting step for tumor [18F]fluoro-2-deoxy- d -glucose (FDG) incorporation
-
Smith, T. A. (2001) The rate-limiting step for tumor [18F]fluoro-2-deoxy- d -glucose (FDG) incorporation Nucl. Med. Biol. 28, 1-4
-
(2001)
Nucl. Med. Biol.
, vol.28
, pp. 1-4
-
-
Smith, T.A.1
-
6
-
-
23944526062
-
Activation of AKT kinases in cancer: Implications for therapeutic targeting
-
Bellacosa, A., Kumar, C. C., Di Cristofano, A., and Testa, J. R. (2005) Activation of AKT kinases in cancer: implications for therapeutic targeting Adv. Cancer Res. 94, 29-86
-
(2005)
Adv. Cancer Res.
, vol.94
, pp. 29-86
-
-
Bellacosa, A.1
Kumar, C.C.2
Di Cristofano, A.3
Testa, J.R.4
-
7
-
-
60549111398
-
Is Akt the "warburg kinase" - Akt-energy metabolism interactions and oncogenesis
-
Robey, R. B. and Hay, N. (2009) Is Akt the "Warburg kinase"- Akt-energy metabolism interactions and oncogenesis Semin. Cancer Biol. 19, 25-31
-
(2009)
Semin. Cancer Biol.
, vol.19
, pp. 25-31
-
-
Robey, R.B.1
Hay, N.2
-
8
-
-
83255162603
-
First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors
-
Yap, T. A., Yan, L., Patnaik, A., Fearen, I., Olmos, D., Papadopoulos, K., Baird, R. D., Delgado, L., Taylor, A., Lupinacci, L., Riisnaes, R., Pope, L. L., Heaton, S. P., Thomas, G., Garrett, M. D., Sullivan, D. M., de Bono, J. S., and Tolcher, A. W. (2011) First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumors J. Clin. Oncol. 29, 4688-4695
-
(2011)
J. Clin. Oncol.
, vol.29
, pp. 4688-4695
-
-
Yap, T.A.1
Yan, L.2
Patnaik, A.3
Fearen, I.4
Olmos, D.5
Papadopoulos, K.6
Baird, R.D.7
Delgado, L.8
Taylor, A.9
Lupinacci, L.10
Riisnaes, R.11
Pope, L.L.12
Heaton, S.P.13
Thomas, G.14
Garrett, M.D.15
Sullivan, D.M.16
De Bono, J.S.17
Tolcher, A.W.18
-
9
-
-
84891947916
-
Phospholipase D2 mediates survival signaling through direct regulation of Akt in glioblastoma cells
-
Bruntz, R. C., Taylor, H. E., Lindsley, C. W., and Brown, H. A. (2014) Phospholipase D2 mediates survival signaling through direct regulation of Akt in glioblastoma cells J. Biol. Chem. 289, 600-616
-
(2014)
J. Biol. Chem.
, vol.289
, pp. 600-616
-
-
Bruntz, R.C.1
Taylor, H.E.2
Lindsley, C.W.3
Brown, H.A.4
-
10
-
-
80054069569
-
Phospholipase D: Enzymology, functionality, and chemical modulation
-
Selvy, P. E., Lavieri, R. R., Lindsley, C. W., and Brown, H. A. (2011) Phospholipase D: enzymology, functionality, and chemical modulation Chem. Rev. 111, 6064-6119
-
(2011)
Chem. Rev.
, vol.111
, pp. 6064-6119
-
-
Selvy, P.E.1
Lavieri, R.R.2
Lindsley, C.W.3
Brown, H.A.4
-
11
-
-
13444268956
-
Requirement of phospholipase D1 activity in H-RasV12-induced transformation
-
Buchanan, F. G., McReynolds, M., Couvillon, A., Kam, Y., Holla, V. R., Dubois, R. N., and Exton, J. H. (2005) Requirement of phospholipase D1 activity in H-RasV12-induced transformation Proc. Natl. Acad. Sci. U.S.A. 102, 1638-1642
-
(2005)
Proc. Natl. Acad. Sci. U.S.A.
, vol.102
, pp. 1638-1642
-
-
Buchanan, F.G.1
McReynolds, M.2
Couvillon, A.3
Kam, Y.4
Holla, V.R.5
Dubois, R.N.6
Exton, J.H.7
-
12
-
-
60149085205
-
Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-κB/Sp1-mediated signaling pathways
-
Park, M., Ahn, B., Hong, Y., and Min, D. (2008) Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-κB/Sp1-mediated signaling pathways Carcinogenesis 30, 356-365
-
(2008)
Carcinogenesis
, vol.30
, pp. 356-365
-
-
Park, M.1
Ahn, B.2
Hong, Y.3
Min, D.4
-
13
-
-
77957907225
-
Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells
-
Toschi, A., Lee, E., Thompson, S., Gadir, N., Yellen, P., Drain, C. M., Ohh, M., and Foster, D. (2010) Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells Cancer Lett. 299, 72-79
-
(2010)
Cancer Lett.
, vol.299
, pp. 72-79
-
-
Toschi, A.1
Lee, E.2
Thompson, S.3
Gadir, N.4
Yellen, P.5
Drain, C.M.6
Ohh, M.7
Foster, D.8
-
14
-
-
0027361047
-
Activation of phospholipase D participates in signal transduction pathways responsive to gamma-radiation
-
Avila, M. A., Otero, G., Cansado, J., Dritschilo, A., Velasco, J. A., and Notario, V. (1993) Activation of phospholipase D participates in signal transduction pathways responsive to gamma-radiation Cancer Res. 53, 4474-4476
-
(1993)
Cancer Res.
, vol.53
, pp. 4474-4476
-
-
Avila, M.A.1
Otero, G.2
Cansado, J.3
Dritschilo, A.4
Velasco, J.A.5
Notario, V.6
-
15
-
-
84855287937
-
Phospholipase D2 (PLD2) shortens the time required for myeloid leukemic cell differentiation: Mechanism of action
-
Di Fulvio, M., Frondorf, K., Henkels, K. M., Grunwald, W. C., Cool, D., and Gomez-Cambronero, J. (2012) Phospholipase D2 (PLD2) shortens the time required for myeloid leukemic cell differentiation: mechanism of action J. Biol. Chem. 287, 393-407
-
(2012)
J. Biol. Chem.
, vol.287
, pp. 393-407
-
-
Di Fulvio, M.1
Frondorf, K.2
Henkels, K.M.3
Grunwald, W.C.4
Cool, D.5
Gomez-Cambronero, J.6
-
16
-
-
77956730942
-
Design, synthesis, and biological evaluation of halogenated N -(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: Discovery of an isoform-selective small molecule phospholipase D2 inhibitor
-
Lavieri, R. R., Scott, S. A., Selvy, P. E., Kim, K., Jadhav, S., Morrison, R. D., Daniels, J. S., Brown, H. A., and Lindsley, C. W. (2010) Design, synthesis, and biological evaluation of halogenated N -(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitor J. Med. Chem. 53, 6706-6719
-
(2010)
J. Med. Chem.
, vol.53
, pp. 6706-6719
-
-
Lavieri, R.R.1
Scott, S.A.2
Selvy, P.E.3
Kim, K.4
Jadhav, S.5
Morrison, R.D.6
Daniels, J.S.7
Brown, H.A.8
Lindsley, C.W.9
-
17
-
-
58249115241
-
Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness
-
Scott, S. A., Selvy, P. E., Buck, J. R., Cho, H. P., Criswell, T. L., Thomas, A. L., Armstrong, M. D., Arteaga, C. L., Lindsley, C. W., and Brown, H. A. (2009) Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness Nat. Chem. Biol. 5, 108-117
-
(2009)
Nat. Chem. Biol.
, vol.5
, pp. 108-117
-
-
Scott, S.A.1
Selvy, P.E.2
Buck, J.R.3
Cho, H.P.4
Criswell, T.L.5
Thomas, A.L.6
Armstrong, M.D.7
Arteaga, C.L.8
Lindsley, C.W.9
Brown, H.A.10
-
18
-
-
61849108279
-
Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificity
-
Lewis, J. A., Scott, S. A., Lavieri, R., Buck, J. R., Selvy, P. E., Stoops, S. L., Armstrong, M. D., Brown, H. A., and Lindsley, C. W. (2009) Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificity Bioorg. Med. Chem. Lett. 19, 1916-1920
-
(2009)
Bioorg. Med. Chem. Lett.
, vol.19
, pp. 1916-1920
-
-
Lewis, J.A.1
Scott, S.A.2
Lavieri, R.3
Buck, J.R.4
Selvy, P.E.5
Stoops, S.L.6
Armstrong, M.D.7
Brown, H.A.8
Lindsley, C.W.9
-
19
-
-
80054856731
-
Metabolomics annotates ABHD3 as a physiologic regulator of medium-chain phospholipids
-
Long, J. Z., Cisar, J. S., Milliken, D., Niessen, S., Wang, C., Trauger, S. A., Siuzdak, G., and Cravatt, B. F. (2011) Metabolomics annotates ABHD3 as a physiologic regulator of medium-chain phospholipids Nat. Chem. Biol. 7, 1-3
-
(2011)
Nat. Chem. Biol.
, vol.7
, pp. 1-3
-
-
Long, J.Z.1
Cisar, J.S.2
Milliken, D.3
Niessen, S.4
Wang, C.5
Trauger, S.A.6
Siuzdak, G.7
Cravatt, B.F.8
-
20
-
-
77953702324
-
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
-
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., Marks, K. M., Prins, R. M., Ward, P. S., Yen, K. E., Liau, L. M., Rabinowitz, J. D., Cantley, L. C., Thompson, C. B., Vander Heiden, M. G., and Su, S. M. (2010) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate Nature 465, 739-744
-
(2010)
Nature
, vol.465
, pp. 739-744
-
-
Dang, L.1
White, D.W.2
Gross, S.3
Bennett, B.D.4
Bittinger, M.A.5
Driggers, E.M.6
Fantin, V.R.7
Jang, H.G.8
Jin, S.9
Keenan, M.C.10
Marks, K.M.11
Prins, R.M.12
Ward, P.S.13
Yen, K.E.14
Liau, L.M.15
Rabinowitz, J.D.16
Cantley, L.C.17
Thompson, C.B.18
Vander Heiden, M.G.19
Su, S.M.20
more..
-
21
-
-
77749305065
-
Simultaneous quantification of intracellular natural and antiretroviral nucleosides and nucleotides by liquid chromatography-tandem mass spectrometry
-
Fromentin, E., Gavegnano, C., Obikhod, A., and Schinazi, R. F. (2010) Simultaneous quantification of intracellular natural and antiretroviral nucleosides and nucleotides by liquid chromatography-tandem mass spectrometry Anal. Chem. 82, 1982-1989
-
(2010)
Anal. Chem.
, vol.82
, pp. 1982-1989
-
-
Fromentin, E.1
Gavegnano, C.2
Obikhod, A.3
Schinazi, R.F.4
-
22
-
-
0037162293
-
High-resolution structure of the pleckstrin homology domain of protein kinase B/Akt bound to phosphatidylinositol (3,4,5)-trisphosphate
-
Thomas, C. C., Deak, M., Alessi, D. R., and van Aalten, D. M. (2002) High-resolution structure of the pleckstrin homology domain of protein kinase B/Akt bound to phosphatidylinositol (3,4,5)-trisphosphate Curr. Biol. 12, 1256-1262
-
(2002)
Curr. Biol.
, vol.12
, pp. 1256-1262
-
-
Thomas, C.C.1
Deak, M.2
Alessi, D.R.3
Van Aalten, D.M.4
-
23
-
-
13844312400
-
Phosphorylation and regulation of Akt/PKB by the RICTOR-mTOR complex
-
Sarbassov, D. (2005) Phosphorylation and regulation of Akt/PKB by the RICTOR-mTOR complex Science 307, 1098-1101
-
(2005)
Science
, vol.307
, pp. 1098-1101
-
-
Sarbassov, D.1
-
24
-
-
0031127305
-
Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha
-
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R., Reese, C. B., and Cohen, P. (1997) Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha Curr. Biol. 7, 261-269
-
(1997)
Curr. Biol.
, vol.7
, pp. 261-269
-
-
Alessi, D.R.1
James, S.R.2
Downes, C.P.3
Holmes, A.B.4
Gaffney, P.R.5
Reese, C.B.6
Cohen, P.7
-
25
-
-
0032578999
-
Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B
-
Stephens, L. (1998) Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B Science 279, 710-714
-
(1998)
Science
, vol.279
, pp. 710-714
-
-
Stephens, L.1
-
26
-
-
0036851697
-
Inhibitors of de novo nucleotide biosynthesis as drugs
-
Christopherson, R. I., Lyons, S. D., and Wilson, P. K. (2002) Inhibitors of de novo nucleotide biosynthesis as drugs Acc. Chem. Res. 35, 961-971
-
(2002)
Acc. Chem. Res.
, vol.35
, pp. 961-971
-
-
Christopherson, R.I.1
Lyons, S.D.2
Wilson, P.K.3
-
27
-
-
34247396011
-
A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC)
-
Ong, S. E. and Mann, M. (2006) A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC) Nat. Protoc. 1, 2650-2660
-
(2006)
Nat. Protoc.
, vol.1
, pp. 2650-2660
-
-
Ong, S.E.1
Mann, M.2
-
28
-
-
84901236412
-
Activation of EGFR and ERBB2 by Helicobacter pylori results in survival of gastric epithelial cells with DNA damage
-
Chaturvedi, R., Asim, M., Piazuelo, M. B., Yan, F., Barry, D. P., Sierra, J. C., Delgado, A. G., Hill, S., Jr., R, A. C., Bravo, L. E., Dominguez, R. L., Correa, P., Polk, D. B., Washington, M. K., Rose, K. L., Schey, K. L., Morgan, D. R., Jr., R, M. P., and Wilson, K. T. (2014) Activation of EGFR and ERBB2 by Helicobacter pylori results in survival of gastric epithelial cells with DNA damage Gastroenterology 146, 1739-1751.e1714
-
(2014)
Gastroenterology
, vol.146
, pp. 1739-1751e1714
-
-
Chaturvedi, R.1
Asim, M.2
Piazuelo, M.B.3
Yan, F.4
Barry, D.P.5
Sierra, J.C.6
Delgado, A.G.7
Hill, S.8
Bravo, L.E.9
Dominguez, R.L.10
Correa, P.11
Polk, D.B.12
Washington, M.K.13
Rose, K.L.14
Schey, K.L.15
Morgan, D.R.16
Wilson, K.T.17
-
29
-
-
0035498939
-
Hierarchical phosphorylation of the translation inhibitor 4E-BP1
-
Gingras, A. C., Raught, B., Gygi, S. P., Niedzwiecka, A., Miron, M., Burley, S. K., Polakiewicz, R. D., Wyslouch-Cieszynska, A., Aebersold, R., and Sonenberg, N. (2001) Hierarchical phosphorylation of the translation inhibitor 4E-BP1 Genes Dev. 15, 2852-2864
-
(2001)
Genes Dev.
, vol.15
, pp. 2852-2864
-
-
Gingras, A.C.1
Raught, B.2
Gygi, S.P.3
Niedzwiecka, A.4
Miron, M.5
Burley, S.K.6
Polakiewicz, R.D.7
Wyslouch-Cieszynska, A.8
Aebersold, R.9
Sonenberg, N.10
-
30
-
-
0035312747
-
Regulation of translation initiation by FRAP/mTOR
-
Gingras, A. (2001) Regulation of translation initiation by FRAP/mTOR Genes Dev. 15, 807-826
-
(2001)
Genes Dev.
, vol.15
, pp. 807-826
-
-
Gingras, A.1
-
31
-
-
73649098283
-
Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation
-
Foster, K., Acosta-Jaquez, H., Romeo, Y., Ekim, B., Soliman, G., Carriere, A., Roux, P., Ballif, B., and Fingar, D. (2010) Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation J. Biol. Chem. 285, 80-94
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 80-94
-
-
Foster, K.1
Acosta-Jaquez, H.2
Romeo, Y.3
Ekim, B.4
Soliman, G.5
Carriere, A.6
Roux, P.7
Ballif, B.8
Fingar, D.9
-
32
-
-
84874995247
-
Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1
-
Ben-Sahra, I., Howell, J. J., Asara, J. M., and Manning, B. D. (2013) Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1 Science 339, 1323-1328
-
(2013)
Science
, vol.339
, pp. 1323-1328
-
-
Ben-Sahra, I.1
Howell, J.J.2
Asara, J.M.3
Manning, B.D.4
-
33
-
-
84874961313
-
Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis
-
Robitaille, A. M., Christen, S., Shimobayashi, M., Cornu, M., Fava, L. L., Moes, S., Prescianotto-Baschong, C., Sauer, U., Jenoe, P., and Hall, M. N. (2013) Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis Science 339, 1320-1323
-
(2013)
Science
, vol.339
, pp. 1320-1323
-
-
Robitaille, A.M.1
Christen, S.2
Shimobayashi, M.3
Cornu, M.4
Fava, L.L.5
Moes, S.6
Prescianotto-Baschong, C.7
Sauer, U.8
Jenoe, P.9
Hall, M.N.10
-
34
-
-
84893586146
-
Structure, functional characterization, and evolution of the dihydroorotase domain of human CAD
-
Grande-García, A., Lallous, N., Díaz-Tejada, C., and Ramón-Maiques, S. (2014) Structure, functional characterization, and evolution of the dihydroorotase domain of human CAD Structure 22, 185-198
-
(2014)
Structure
, vol.22
, pp. 185-198
-
-
Grande-García, A.1
Lallous, N.2
Díaz-Tejada, C.3
Ramón-Maiques, S.4
-
35
-
-
18344413122
-
Regulation of carbamoyl phosphate synthetase by MAP kinase
-
Graves, L. M., Guy, H. I., Kozlowski, P., Huang, M., Lazarowski, E., Pope, R. M., Collins, M. A., Dahlstrand, E. N., Earp, H. S., and Evans, D. R. (2000) Regulation of carbamoyl phosphate synthetase by MAP kinase Nature 403, 328-332
-
(2000)
Nature
, vol.403
, pp. 328-332
-
-
Graves, L.M.1
Guy, H.I.2
Kozlowski, P.3
Huang, M.4
Lazarowski, E.5
Pope, R.M.6
Collins, M.A.7
Dahlstrand, E.N.8
Earp, H.S.9
Evans, D.R.10
-
36
-
-
77951072181
-
Metabolomic analysis via reversed-phase ion-pairing liquid chromatography coupled to a stand alone orbitrap mass spectrometer
-
Lu, W., Clasquin, M. F., Melamud, E., Amador-Noguez, D., Caudy, A. A., and Rabinowitz, J. D. (2010) Metabolomic analysis via reversed-phase ion-pairing liquid chromatography coupled to a stand alone orbitrap mass spectrometer Anal. Chem. 82, 3212-3221
-
(2010)
Anal. Chem.
, vol.82
, pp. 3212-3221
-
-
Lu, W.1
Clasquin, M.F.2
Melamud, E.3
Amador-Noguez, D.4
Caudy, A.A.5
Rabinowitz, J.D.6
-
37
-
-
0036783739
-
Selective estrogen receptor (ER) modulators differentially regulate phospholipase D catalytic activity in ER-negative breast cancer cells
-
Eisen, S. F. and Brown, H. A. (2002) Selective estrogen receptor (ER) modulators differentially regulate phospholipase D catalytic activity in ER-negative breast cancer cells Mol. Pharmacol. 62, 911-920
-
(2002)
Mol. Pharmacol.
, vol.62
, pp. 911-920
-
-
Eisen, S.F.1
Brown, H.A.2
-
38
-
-
84903275752
-
Chemical modulation of glycerolipid signaling and metabolic pathways
-
Scott, S. A., Mathews, T. P., Ivanova, P. T., Lindsley, C. W., and Brown, H. A. (2014) Chemical modulation of glycerolipid signaling and metabolic pathways Biochim. Biophys. Acta, Mol. Cell Biol. Lipids 1841, 1060-1084
-
(2014)
Biochim. Biophys. Acta, Mol. Cell Biol. Lipids
, vol.1841
, pp. 1060-1084
-
-
Scott, S.A.1
Mathews, T.P.2
Ivanova, P.T.3
Lindsley, C.W.4
Brown, H.A.5
-
39
-
-
77956319781
-
In vitro mechanism of action for the cytotoxicity elicited by the combination of epigallocatechin gallate and raloxifene in MDA-MB-231 cells
-
Stuart, E. C., Jarvis, R. M., and Rosengren, R. J. (2010) In vitro mechanism of action for the cytotoxicity elicited by the combination of epigallocatechin gallate and raloxifene in MDA-MB-231 cells Oncol. Rep. 24, 779-785
-
(2010)
Oncol. Rep.
, vol.24
, pp. 779-785
-
-
Stuart, E.C.1
Jarvis, R.M.2
Rosengren, R.J.3
-
40
-
-
33645241260
-
The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle
-
Hornberger, T. A., Chu, W. K., Mak, Y. W., Hsiung, J. W., Huang, S. A., and Chien, S. (2006) The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle Proc. Natl. Acad. Sci. U.S.A. 103, 4741-4746
-
(2006)
Proc. Natl. Acad. Sci. U.S.A.
, vol.103
, pp. 4741-4746
-
-
Hornberger, T.A.1
Chu, W.K.2
Mak, Y.W.3
Hsiung, J.W.4
Huang, S.A.5
Chien, S.6
-
41
-
-
40549088524
-
PLD regulates myoblast differentiation through the mTOR-IGF2 pathway
-
Yoon, M. S. and Chen, J. (2008) PLD regulates myoblast differentiation through the mTOR-IGF2 pathway J. Cell Sci. 121, 282-289
-
(2008)
J. Cell Sci.
, vol.121
, pp. 282-289
-
-
Yoon, M.S.1
Chen, J.2
-
42
-
-
84880082416
-
Regulation of phospholipase D activity and phosphatidic acid production after purinergic (P2Y6) receptor stimulation
-
Scott, S., Xiang, Y., Mathews, T., Cho, H., Myers, D., Armstrong, M., Tallman, K., O'Reilly, M., Lindsley, C., and Brown, H. (2013) Regulation of phospholipase D activity and phosphatidic acid production after purinergic (P2Y6) receptor stimulation J. Biol. Chem. 288, 20477-20487
-
(2013)
J. Biol. Chem.
, vol.288
, pp. 20477-20487
-
-
Scott, S.1
Xiang, Y.2
Mathews, T.3
Cho, H.4
Myers, D.5
Armstrong, M.6
Tallman, K.7
O'Reilly, M.8
Lindsley, C.9
Brown, H.10
-
43
-
-
78650510609
-
MTOR: From growth signal integration to cancer, diabetes and ageing
-
Zoncu, R., Efeyan, A., and Sabatini, D. M. (2011) mTOR: from growth signal integration to cancer, diabetes and ageing Nat. Rev. Mol. Cell Biol. 12, 21-35
-
(2011)
Nat. Rev. Mol. Cell Biol.
, vol.12
, pp. 21-35
-
-
Zoncu, R.1
Efeyan, A.2
Sabatini, D.M.3
-
44
-
-
65549145048
-
An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1
-
Thoreen, C. C., Kang, S. A., Chang, J. W., Liu, Q., Zhang, J., Gao, Y., Reichling, L. J., Sim, T., Sabatini, D. M., and Gray, N. S. (2009) An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1 J. Biol. Chem. 284, 8023-8032
-
(2009)
J. Biol. Chem.
, vol.284
, pp. 8023-8032
-
-
Thoreen, C.C.1
Kang, S.A.2
Chang, J.W.3
Liu, Q.4
Zhang, J.5
Gao, Y.6
Reichling, L.J.7
Sim, T.8
Sabatini, D.M.9
Gray, N.S.10
-
45
-
-
84858082548
-
MTOR inhibitors in cancer therapy
-
Zaytseva, Y. Y., Valentino, J. D., Gulhati, P., and Evers, B. M. (2012) mTOR inhibitors in cancer therapy Cancer Lett. 319, 1-7
-
(2012)
Cancer Lett.
, vol.319
, pp. 1-7
-
-
Zaytseva, Y.Y.1
Valentino, J.D.2
Gulhati, P.3
Evers, B.M.4
-
46
-
-
84907185222
-
Phospholipase D facilitates efficient entry of influenza virus allowing escape from innate immune inhibition
-
Oguin, T. H., Sharma, S., Stuart, A. D., Duan, S., Scott, S. A., Jones, C. K., Daniels, J. S., Lindsley, C. W., Thomas, P. G., and Brown, H. A. (2014) Phospholipase D facilitates efficient entry of influenza virus allowing escape from innate immune inhibition J. Biol. Chem. 289, 25405-25417
-
(2014)
J. Biol. Chem.
, vol.289
, pp. 25405-25417
-
-
Oguin, T.H.1
Sharma, S.2
Stuart, A.D.3
Duan, S.4
Scott, S.A.5
Jones, C.K.6
Daniels, J.S.7
Lindsley, C.W.8
Thomas, P.G.9
Brown, H.A.10
-
47
-
-
84964312418
-
Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer
-
Bruntz, R. C., Lindsley, C. W., and Brown, H. A. (2014) Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer Pharmacol. Rev. 66, 1033-1079
-
(2014)
Pharmacol. Rev.
, vol.66
, pp. 1033-1079
-
-
Bruntz, R.C.1
Lindsley, C.W.2
Brown, H.A.3
-
48
-
-
84923377448
-
Discovery of desketoraloxifene analogues as inhibitors of mammalian, Pseudomonas aeruginosa, and NAPE phospholipase D enzymes
-
Scott, S. A., Spencer, C. T., O'Reilly, M. C., Brown, K. A., Lavieri, R. L., Cho, C. H., Jung, D. I., Larock, R. C., Brown, H. A., and Lindsley, C. W. (2014) Discovery of desketoraloxifene analogues as inhibitors of mammalian, Pseudomonas aeruginosa, and NAPE phospholipase D enzymes ACS Chem. Biol. 10.1021/cb500828m
-
(2014)
ACS Chem. Biol.
-
-
Scott, S.A.1
Spencer, C.T.2
O'Reilly, M.C.3
Brown, K.A.4
Lavieri, R.L.5
Cho, C.H.6
Jung, D.I.7
Larock, R.C.8
Brown, H.A.9
Lindsley, C.W.10
|